Hutchison China Meditech Files For U.S. IPO

(RTTNews) - Hutchison China MediTech Ltd. (HCM.L) or Chi-Med said that it has publicly filed today a registration statement on Form F-1 with the United States Securities and Exchange Commission in relation to the potential Offering.

In Friday's regular trading HCM.L is trading at 2,090.00 pence, up 157.50 pence or 8.15%.

The company noted that it is evaluating the feasibility of a potential issuance of new Ordinary Shares in connection with a potential listing of American depositary shares or "ADSs" representing such Ordinary Shares on the Nasdaq Stock Market.

The Offering will be made only by means of an effective Form F-1 Registration Statement. As at the date of this announcement, Chi-Med has not yet set a definite timetable or decided on further details of the potential Offering and there can be no assurance that the potential Offering will be completed. The number of offering shares and offering price of the potential Offering have not yet been determined. The directors of Chi-Med will assess various factors, including market conditions, in considering whether to formally launch the transaction.

Bank of America Merrill Lynch and Deutsche Bank Securities are acting as joint global coordinators and joint bookrunners for the potential Offering.